In the present study, we have determined the prognostic value of ERG and other ETS genes in a large, multisampled, prospective cohort of primary prostate cancer patients with long‐term follow‐up, while considering multifocality, heterogeneity, and persistent PSA. This evidence concerns the gene ERG and prostate carcinoma.